Cwm, LLC Intercept Pharmaceuticals, Inc. Transaction History

Cwm, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	BUY	$9.99 - $18.71 $19 - $37	2 Added 18.18%	13 $0
Q2 2023 Aug 03, 2023	SELL	$9.17 - $19.29 $761 - $1,601	-83 Reduced 88.3%	11 $0
Q1 2023 Apr 28, 2023	BUY	$12.53 - $21.71 $1,177 - $2,040	94 New	94 $1,000
Q2 2022 Jul 28, 2022	BUY	$11.23 - $19.59 $101 - $176	9 New	9 $0
Q1 2018 Apr 26, 2018	SELL	$52.72 - $67.25 $1,212 - $1,546	-23 Closed	0 $0
Q4 2017 Jan 16, 2018	BUY	$58.2 - $72.76 $1,338 - $1,673	23	23 $1,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.